Results 31 to 40 of about 7,240 (211)

Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis

Haematologica, 2019
Here we critically evaluate the role of elevated hematocrit as the principal determinant of thrombotic risk in polycythemia and erythrocytosis, defined by an expansion of red cell mass.
Victor R. Gordeuk, Nigel S. Key, Josef T. Prchal   +2 more
doaj   +1 more source

Haematological parameters of blood donors with erythrocytosis [PDF]

, 2019
Background: It is mandatory for all blood donors to have their haemoglobin values tested before blood donation. High haemoglobin levels may indicate an underlying hidden pathological condition.Aim: Our aim was to assess the frequency of erythrocytosis in
Ramli, M, Hasan, M, Noor, N, Jamian, E, Othman, M, Kamaruzzaman, S, Abdullah, W   +6 more
core   +2 more sources

Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. [PDF]

, 2009
BACKGROUND: High oxygen-affinity haemoglobin variants and 2,3-diphosphoglycerate (2,3-DPG) deficiency are inherited diseases generating low tissue oxygen tension and erythropoietin-driven erythrocytosis, that characterizes the clinical phenotype of ...
Cazzola M, Pietra D, Elena C, Tedesco R, PASSAMONTI, FRANCESCO, Ammirabile M, Pagano L, Flagiello A, Arcaini L, Marcello AP, Rumi E, Vercellati C, Moratti R, Lazzarino M.   +13 more
core   +3 more sources

Associations of Long-Term Exposure to PM_2.5 and Its Constituents with Erythrocytosis and Thrombocytosis in Rural Populations

Toxics, 2023
Evidence on the effect of long-term exposure to fine particulate matter (PM2.5) on erythrocytosis and thrombocytosis prevalence was limited. We aimed to investigate the association of PM2.5 and its constituents with the risks of erythrocytosis and ...
Yiquan Zheng, Yaling He, Ning Kang, Caiyun Zhang, Wei Liao, Yinghao Yuchi, Xiaotian Liu, Jian Hou, Zhenxing Mao, Wenqian Huo, Kai Zhang, Hezhong Tian, Hualiang Lin, Chongjian Wang   +13 more
doaj   +1 more source

Erythrocytosis is associated with intradialytic hypotension: a case series

BMC Nephrology, 2019
Background For patients with end stage renal disease undergoing hemodialysis, erythrocytosis occurs rarely. Erythrocytosis increases the risk of thrombosis, which is a common complication in hemodialysis patients.
Shree Agrawal, Preethi Ramachandran, Rupinder Gill, Samuel Spitalewitz, Douglas Gunzler, Marcia R. Silver, Edward J. Horwitz, Jeffrey R. Schelling   +7 more
doaj   +1 more source

Familial erythrocytosis 2 and von Hippel-Lindau disease in the same pediatric patient

Boletín Médico del Hospital Infantil de México, 2021
Background: Patients with familial erythrocytosis type 2 have no increased risk of von Hippel-Lindau-associated tumors, although mutations in the VHL gene cause both pathologies.
Paulina M. Núñez-Martínez, Lucía Taja-Chayeb, Miguel A. Ramírez-Otero, Verónica Fragoso-Ontiveros, Talia Wegman-Ostrosky, David Cruz-Robles, Silvia Vidal-Millán   +6 more
doaj   +1 more source

Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera

Chinese Journal of Cancer, 2017
Background Erythrocytosis, a rare paraneoplastic syndrome, generally occurs in patients with clear cell renal cell carcinoma and has never been reported in patients with chromophobe renal cell carcinoma.
Renbo Guo, Yiran Liang, Lei Yan, Zhonghua Xu, Juchao Ren   +4 more
doaj   +1 more source

An Unusual Occurrence of Erythrocytosis in a Child with Nephrotic Syndrome and Advanced Chronic Kidney Disease

Pediatric Reports, 2021
Background: Anemia is common in patients with nephrotic syndrome (NS) for various reasons. Furthermore, anemia can occur in patients with chronic kidney disease (CKD) predominantly owing to inappropriately low erythropoietin (EPO) production relative to ...
Ratna Acharya, Kiran Upadhyay
doaj   +1 more source

RECENT INSIGHTS INTO SECONDARY ERYTHROCYTOSIS: PART I. ETIOLOGY

Клінічна та профілактична медицина
Introduction. The development of secondary erythrocytosis is associated with a wide range of both hereditary and acquired pathological conditions. Modern advances in medicine have deepened the understanding of the etiology and pathogenesis of secondary ...
Mariia A. Trypilka, Oksana M. Kostiukevych, Lesia K. Benkovska   +2 more
doaj   +1 more source

Enalaprilat and losartan decrease erythroid precursors frequency in cells from patients with polycythemia vera

Hematology, 2023
Objective: Polycythemia Vera (PV) is a myeloproliferative neoplasm characterized by the overproduction of red blood cells. First-line therapies are directed at lowering hematocrit levels. After the discovery of a mutation in the Janus kinase 2 (JAK2V617F)
Angela Bozza, Martina Bernardi, Daniela Catanzaro, Katia Chieregato, Anna Merlo, Giuseppe Astori   +5 more
doaj   +1 more source